Adding to the list of pharma majors starting or expanding production in the USA, Swiss pharma giant Roche today announced that it will invest $50 billion into America in the next five years.
These investments further strengthen Roche’s already significant US footprint with 13 manufacturing and 15 R&D sites across the Pharmaceutical and Diagnostics Divisions, and are expected to create more than 12,000 new jobs, including nearly 6,500 construction jobs, as well as 1,000 jobs at new and expanded facilities.
Read the article.